The eraser ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 through m6A abolishment, decreasing WIF-1 RNA methylation and mediating Wnt signaling (10, 11). This evidence concerns the gene ALKBH5 and familial pancreatic carcinoma.